Ubs Oconnor LLC Annexon, Inc. Call Options Transaction History

Ubs Oconnor LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $1.69 Million - $3.27 Million	418,500 New	418,500 $3 Million
Q3 2023 Nov 14, 2023	SELL	$2.13 - $3.84 $106,500 - $192,000	-50,000 Reduced 14.29%	300,000 $708,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $735,000 - $2.23 Million	350,000 New	350,000 $91.3 Million

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.